RSS Subscribe to our Nanotechnology Business News feed

Importance of On-Dose Technologies in the Fight Against Illegal Diversion of Pain Medication

NanoGuardian, a division of NanoInk that delivers brand protection solutions to fight illegal diversion and counterfeiting, announced today that pharmaceutical security expert and co-founder of the Pharmaceutical Security Institute, Dr. John Glover, published a white paper extolling necessary requirements of the Food and Drug Administration-proposed Risk Evaluation and Mitigation Strategies for opioid products, commonly referred to as pain medications.

May 6th, 2009

Read more